In a patient with diarrhea‑predominant IBS who experiences urgent watery stools after meals, no nocturnal bowel movements, and has a history of cholecystectomy, how does bile‑acid diarrhoea develop?

How Bile Acid Diarrhoea Occurs in IBS

Bile acid diarrhoea (BAD) develops in IBS through two primary mechanisms: deficiency of fibroblast growth factor 19 (FGF-19) leading to hepatic bile acid overproduction, and malabsorption of bile acids in the terminal ileum, both of which result in excess bile acids reaching the colon where they stimulate secretion and accelerate motility. 1

Primary Pathophysiological Mechanisms

FGF-19 Deficiency and Bile Acid Overproduction

• The most common mechanism in idiopathic BAD (Type 2) is deficiency of FGF-19, a hormone produced by enterocytes that normally provides negative feedback to suppress hepatic bile acid synthesis. 1
• When FGF-19 levels are inadequate, the liver continues to overproduce bile acids despite adequate amounts already circulating, overwhelming the terminal ileum's reabsorptive capacity. 1
• This interruption of normal enterohepatic feedback loops causes excessive bile acid delivery to the colon even without structural intestinal disease. 2

Terminal Ileal Dysfunction

• Even short segments of ileal resection (>5 cm) increase the risk of bile acid malabsorption by reducing the absorptive surface area for bile acid reuptake. 3
• In unoperated patients with IBS-D, functional impairment of ileal bile acid transporters may occur without visible structural damage. 1
• Genetic variations affecting proteins involved in bile acid enterohepatic circulation and synthesis contribute to individual susceptibility. 1

Post-Cholecystectomy BAD

In your patient with prior cholecystectomy, BAD occurs through loss of the gallbladder's storage and regulated release function, resulting in continuous bile acid delivery to the intestine rather than meal-stimulated boluses. 3

• Cholecystectomy is associated with 78% prevalence of moderate BAD (SeHCAT <10%) and 86% prevalence of at least mild BAD (SeHCAT <15%). 3
• Without gallbladder storage, bile acids continuously trickle into the duodenum, overwhelming the terminal ileum's capacity for reabsorption between meals. 3
• This explains the postprandial urgency your patient experiences—meals trigger additional bile acid secretion on top of the already continuous baseline flow. 3

Colonic Effects of Excess Bile Acids

Direct Secretory and Motor Effects

• Bile acids enhance mucosal permeability, induce water and electrolyte secretion, and accelerate colonic transit partly by stimulating propulsive high-amplitude colonic contractions. 1
• The TGR5 receptor mediates bile acid actions on colonic secretion and motility, explaining the urgent watery stools characteristic of BAD. 1
• Transit time is dysregulated in the absence of the "ileal brake," and bile acids directly affect intestinal motility. 3

Microbiome Alterations

• There is an increased proportion of primary bile acids in the stool of patients with IBS-D, as the gut microbiota has insufficient time to dehydroxylate primary to secondary bile acids. 1
• The gut microbiome is significantly different in patients with severe BAD, with reduced bacterial species capable of bile acid dehydroxylation. 2, 4

Clinical Presentation Distinguishing BAD from Pure IBS

Key Atypical Features

• Nocturnal diarrhea (waking from sleep to defecate) is never a feature of IBS and strongly suggests BAD or other organic pathology. 3, 5
• Your patient's absence of nocturnal symptoms is consistent with either diagnosis, but the cholecystectomy history makes BAD highly probable. 3
• Postprandial urgency with watery stools is characteristic of BAD due to meal-triggered bile acid secretion overwhelming colonic absorptive capacity. 3

Prevalence in IBS-D Population

• 25% to 50% of patients with functional diarrhea or IBS-D have evidence of BAD, making it one of the most common misdiagnosed conditions. 1
• One-third (33%) of patients with IBS-D have BAM when properly tested with SeHCAT or serum C4. 6
• Up to 30% of IBS-D patients are actually misdiagnosed BAD cases. 2

Diagnostic Approach in This Clinical Context

Given the cholecystectomy history, the British Society of Gastroenterology recommends SeHCAT scanning or serum 7α-hydroxy-4-cholesten-3-one (C4) testing to exclude bile acid diarrhoea before attributing symptoms to IBS. 3

Specific Testing Recommendations

• SeHCAT retention <15% at 7 days indicates BAD, with severity classified as mild (10-15%), moderate (5-10%), and severe (0-5%). 7
• Serum C4 concentration >47.1 ng/mL reliably identifies BAD with 95% negative predictive value. 7
• In patients with cholecystectomy, the odds ratio for BAD is 5.70 (95% CI: 2.42-13.46), making testing particularly high-yield. 3

When Testing Is Unavailable

• An empiric trial of bile acid sequestrants is reasonable when BAD is clinically suspected and testing is unavailable. 7
• Approximately 70% of patients with BAD achieve symptom relief with bile acid sequestrants regardless of underlying cause. 7, 6

Common Pitfalls to Avoid

• Do not attribute symptoms to IBS if they developed after cholecystectomy when no IBS existed before surgery—this risks missing treatable BAD. 3
• Absence of nocturnal symptoms does not exclude BAD; many BAD patients have purely daytime symptoms. 3
• Lack of response to cholestyramine does not exclude BAD—44% of patients who fail cholestyramine respond after switching to colesevelam. 7
• Do not use bile acid sequestrants in patients with extensive ileal resection (>100 cm) as they worsen steatorrhea. 7